Management of Small Intestinal Bacterial Overgrowth (SIBO) in Gastrointestinal Amyloidosis Introduction Small intestinal bacterial overgrowth (SIBO) is an underappreciated complication […]

Dietary Changes in Gastrointestinal Amyloidosis: Enhancing Symptoms and Nutrition Introduction Systemic amyloidosis with GI involvement is an ubiquitous and problematic

Pharmacologic Treatment of Gastric Symptoms in Gastrointestinal Amyloidosis Introduction Gastrointestinal (GI) amyloidosis is a manifestation of systemic amyloidosis that involves

Endoscopic Biopsies to Detect Gastrointestinal Amyloidosis: Sensitivity and Limitations Introduction It is frequent and clinically relevant in systemic amyloidosis that

Management of Erectile Dysfunction in Amyloidosis: Pharmacologic and Clinical Approaches Introduction Erectile dysfunction (ED) is an underdiagnosed but frequent complication

Gastrointestinal Symptoms of Systemic Amyloidosis: Identification and Management Introduction Gastrointestinal (GI) involvement is a frequent and clinically relevant manifestation of

Pharmacologic Management of Urinary Urgency in Amyloidosis Introduction Urinary frequency and urgency are troublesome and frequent symptoms in systemic amyloidosis

First-Line Pharmacological Treatment for Orthostatic Hypotension in Amyloidosis: Midodrine and Droxidopa Introduction Orthostatic hypotension (OH) is common and disabling in

Supine Hypertension in Amyloidosis: Definition and Management Strategies Introduction Supine hypertension has long been an underdiagnosed and undertreated complication in

Implantable Cardioverter-Defibrillators (ICDs) in Cardiac Amyloidosis: Do They Really Help? 1. Introduction Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy due